SGLT‐2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 Diabetes.
Saved in:
| Title: | SGLT‐2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 Diabetes. |
|---|---|
| Authors: | Kim, Do Han1 (AUTHOR) dohan.kim@mountsinai.org, Ko, Donghyun2 (AUTHOR), Chen, Vincent L.3 (AUTHOR), Porres, Jose A.4 (AUTHOR), Elizondo Alatorre, Carlos5 (AUTHOR), Nieto, Luis M.6 (AUTHOR), Palacios Argueta, Pedro7 (AUTHOR), Kröner, Paul T.8 (AUTHOR), Lukens, Frank J.9 (AUTHOR), Kim, Donghee10 (AUTHOR), Karagozian, Raffi11 (AUTHOR), Bansal, Meena B.12 (AUTHOR), Wijarnpreecha, Karn13,14,15 (AUTHOR) |
| Source: | Liver International. Feb2026, Vol. 46 Issue 2, p1-10. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14783223 |
|---|---|
| DOI: | 10.1111/liv.70490 |
